当前位置:首页 - 行情中心 - 博济医药(300404) - 财务分析 - 现金流量表

博济医药

(300404)

  

流通市值:35.49亿  总市值:47.95亿
流通股本:2.86亿   总股本:3.86亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金442,830,372.21187,529,744.21865,099,427.17578,586,582.28
  收到其他与经营活动有关的现金19,273,008.728,959,576.3965,172,592.8137,794,982.87
  经营活动现金流入小计462,103,380.93196,489,320.6930,272,019.98616,381,565.15
  购买商品、接受劳务支付的现金227,665,000.696,282,682.37401,718,137.35290,206,511.22
  支付给职工以及为职工支付的现金180,690,332.9190,739,664.36349,143,166.48254,184,463.89
  支付的各项税费27,729,654.5611,756,426.9148,133,702.828,928,772.49
  支付其他与经营活动有关的现金22,926,083.168,839,957.8644,268,696.8135,266,842.65
  经营活动现金流出小计459,011,071.23207,618,731.5843,263,703.44608,586,590.25
  经营活动产生的现金流量净额3,092,309.7-11,129,410.987,008,316.547,794,974.9
二、投资活动产生的现金流量:
  收回投资收到的现金3,926,673.691,382,041.699,174,117.815,499,117.81
  取得投资收益收到的现金4,440,799.04873,928.62,207,761.881,075,198.42
  处置固定资产、无形资产和其他长期资产收回的现金净额11,303.718,663.712,7502,750
  收到的其他与投资活动有关的现金338,537,75096,000,000472,100,000349,700,000
  投资活动现金流入小计346,916,526.4498,264,634483,484,629.69356,277,066.23
  购建固定资产、无形资产和其他长期资产支付的现金6,149,034.23,078,088.4318,706,735.3614,842,659.39
  投资支付的现金--7,580,4301,280,430
  支付其他与投资活动有关的现金404,522,649.4270,500,000503,600,000491,600,000
  投资活动现金流出小计410,671,683.6273,578,088.43529,887,165.36507,723,089.39
  投资活动产生的现金流量净额-63,755,157.16-175,313,454.43-46,402,535.67-151,446,023.16
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,155,435.881,090,238.2826,430,489.2925,588,613.11
  其中:子公司吸收少数股东投资收到的现金--125,000-
  取得借款收到的现金6,056,275.956,275.944,689,70043,189,700
  收到其他与筹资活动有关的现金25,976,038.9825,799,247.23191,668.55170,559.96
  筹资活动现金流入小计34,187,750.7626,945,761.4171,311,857.8468,948,873.07
  偿还债务支付的现金5,764,742.51,800,00045,505,520.8542,549,914.16
  分配股利、利润或偿付利息支付的现金5,590,567.94286,809.786,122,976.355,332,110.89
  其中:子公司支付给少数股东的股利、利润--200,000-
  支付其他与筹资活动有关的现金2,594,339.69443,733.82,754,772.032,473,663.94
  筹资活动现金流出小计13,949,650.132,530,543.5854,383,269.2350,355,688.99
  筹资活动产生的现金流量净额20,238,100.6324,415,217.8316,928,588.6118,593,184.08
四、汇率变动对现金及现金等价物的影响-950,087.85-490,207.28-662,292.83-333,707.79
五、现金及现金等价物净增加额-41,374,834.68-162,517,854.7856,872,076.65-125,391,571.97
  加:期初现金及现金等价物余额325,430,707.48325,430,707.48268,558,630.83268,558,630.83
  期末现金及现金等价物余额284,055,872.8162,912,852.7325,430,707.48143,167,058.86
补充资料:
  净利润37,748,290.32-32,909,794.36-
  资产减值准备10,332,615.32-30,107,922.37-
  固定资产和投资性房地产折旧12,519,031.94-24,889,531.26-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧12,519,031.94-24,889,531.26-
  无形资产摊销686,361.16-1,266,085.94-
  长期待摊费用摊销1,365,090.33-7,241,563.89-
  固定资产报废损失14,543.73-5,367.44-
  公允价值变动损失-1,742,517.15--1,482,850.18-
  财务费用432,656.09-1,609,163.99-
  投资损失-11,981,021.59--837,663.49-
  递延所得税-1,835,227.41--12,156,938.67-
  其中:递延所得税资产减少-1,940,287.69--11,874,430.91-
    递延所得税负债增加105,060.28--282,507.76-
  存货的减少-16,178,284.18--41,936,456.21-
  经营性应收项目的减少-37,361,487.81--80,699,046.9-
  经营性应付项目的增加8,431,291.38-124,107,818.76-
  不涉及现金收支的投资和筹资活动金额其他项目335,793.29-526,664.74-
  现金的期末余额284,055,872.8-325,430,707.48-
  减:现金的期初余额325,430,707.48-268,558,630.83-
  现金及现金等价物的净增加额-41,374,834.68-56,872,076.65-
公告日期2026-08-272026-04-252026-04-252025-10-29
审计意见(境内)标准无保留意见
TOP↑